Emerald Investment Advisers LLC Invests $5.14 Million in Astera Labs, Inc. $ALAB

Posted by Brenda Bartman on Aug 22nd, 2026

Emerald Investment Advisers LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,638 shares of the company’s stock, valued at approximately $5,138,000.

Several other hedge funds have also modified their holdings of the stock. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter worth approximately $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the second quarter valued at approximately $25,000. Smartleaf Asset Management LLC grew its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs during the fourth quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC raised its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 419,244 shares of company stock worth $163,135,169. Corporate insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ALAB shares. Bank of America boosted their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Barclays lifted their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Morgan Stanley boosted their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective on the stock in a report on Monday, August 17th. Finally, Stifel Nicolaus upped their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $333.00.

Read Our Latest Stock Analysis on ALAB

Astera Labs Trading Down 1.9%

ALAB stock opened at $284.97 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market capitalization of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84. The firm has a 50 day simple moving average of $352.70 and a 200-day simple moving average of $244.92.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.